Alvotech (ALVO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Alvotech (ALVO) is Neutral.

The composite score behind that read is -0.06, weighing +0.38 of bullish evidence against -0.15 bearish.

Alvotech last closed at $6.11, +12.11% on the session.

Against the IVW growth benchmark the position is +11.19% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

Alvotech has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Alvotech in the 95th percentile on return on equity, where 100 is best.

Alvotech is classified under Health Care / Biotechnology, with a market capitalisation of $1.94B.

StockMap tracks Alvotech as the 85th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Alvotech ranks 53rd of 344 in the group, against a group median of -0.21.